Open AccessErratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
Author(s) -
Christian Hampp,
Richard S. Swain,
Casie Horgan,
Elizabeth Dee,
Yandong Qiang,
Sarah K. Dutcher,
Andrew B. Petrone,
Rong Chen Tilney,
Judith C. Maro,
Catherine A. Panozzo
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc20-er09a
Subject(s) - medicine , diabetic ketoacidosis , diabetes mellitus , medicaid , food and drug administration , type 2 diabetes , ketoacidosis , type 1 diabetes , intensive care medicine , pediatrics , endocrinology , health care , pharmacology , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom